Loading...
Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
Despite numerous therapies that effectively inhibit estrogen signaling in breast cancer, a significant proportion of patients with estrogen receptor (ER)-positive malignancy will succumb to their disease. Herein we demonstrate that long-term estrogen deprivation (LTED) therapy among ER-positive brea...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4253418/ https://ncbi.nlm.nih.gov/pubmed/24979294 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|